Related Experiment Video
Updated: Aug 21, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
The biological function of m6A methyltransferase KIAA1429 and its role in human disease
Xiaoyu Zhang1, Meng Jiao Li2, Lei Xia3
1Shandong University of Traditional Chinese Medicine, Jinan, China.
Abstract:
KIAA1429 is a major m6A methyltransferase, which plays important biological and pharmacological roles in both human cancer or non-cancer diseases. KIAA1429 produce a tumorigenic role in various cancers through regulating DAPK3, ID2, GATA3, SMC1A, CDK1, SIRT1 and other targets, promoting cell proliferation, migration, invasion, metastasis and tumor growth . At the same time, KIAA1429 is also effective in non-tumor diseases, such as reproductive system and cardiovascular system diseases. The potential regulatory mechanism of KIAA1429 dependent on m6A modification is related to mRNA, lncRNA, circRNA and miRNAs. In this review, we summarized the current evidence on KIAA1429 in various human cancers or non-cancer diseases and its potential as a prognostic target.
Insights
KIAA1429, a key m6A methyltransferase, impacts human cancers and non-cancer diseases by regulating cell functions. This review highlights its role and potential as a prognostic target.
Area of Science:
- Molecular Biology
- Oncology
- Epigenetics
Background:
- KIAA1429 is a crucial m6A methyltransferase with significant roles in human health and disease.
- It influences tumorigenesis by regulating key targets involved in cell proliferation, migration, invasion, metastasis, and tumor growth.
- Beyond cancer, KIAA1429 affects non-tumor diseases, including those of the reproductive and cardiovascular systems.
Approach:
- This review synthesizes current research on KIAA1429's involvement in various human cancers.
- It examines KIAA1429's function in non-cancerous conditions.
- The review explores the regulatory mechanisms of KIAA1429-dependent m6A modification across different RNA types (mRNA, lncRNA, circRNA, miRNA).
Key Points:
- KIAA1429 promotes cancer progression through specific molecular targets like DAPK3, ID2, GATA3, SMC1A, CDK1, and SIRT1.
- The methyltransferase activity of KIAA1429 is implicated in both oncogenic and non-oncogenic disease pathways.
- m6A modification mediated by KIAA1429 involves interactions with various RNA molecules, influencing gene expression.
Conclusions:
- KIAA1429 is a significant player in oncogenesis and other diseases.
- Understanding KIAA1429's mechanisms offers insights into disease pathology.
- KIAA1429 presents potential as a prognostic biomarker and therapeutic target in diverse human diseases.
Related Concept Videos
RNA Editing
Biosynthesis of Nucleic Acids
Epigenetic Regulation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Master Transcription Regulators
Translation
Translation Produces the Building Blocks of Life
Proteins are...

